HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chia-Ling Chen Selected Research

Hypoxia (Hypoxemia)

8/2021Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study.
1/2021Hypoxia-induced preadipocyte factor 1 expression in human lung fibroblasts through ERK/PEA3/c-Jun pathway.
1/2011Apoptotic sphingolipid ceramide in cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chia-Ling Chen Research Topics

Disease

28Stroke (Strokes)
04/2024 - 03/2010
25Infections
01/2023 - 01/2012
24Neoplasms (Cancer)
04/2024 - 04/2008
16Inflammation (Inflammations)
01/2022 - 07/2009
8Cerebral Palsy (Spastic Diplegia)
01/2024 - 04/2004
7Breast Neoplasms (Breast Cancer)
04/2024 - 01/2014
6Fibrosis (Cirrhosis)
04/2024 - 01/2021
5Neoplasm Metastasis (Metastasis)
04/2024 - 01/2014
5Leukemia
05/2023 - 05/2009
5Ischemic Stroke
08/2021 - 01/2015
5Necrosis
07/2021 - 01/2010
5Adenocarcinoma of Lung
09/2019 - 05/2012
4Lung Neoplasms (Lung Cancer)
05/2023 - 04/2010
3Asthma (Bronchial Asthma)
04/2024 - 08/2021
3Pneumonia (Pneumonitis)
01/2022 - 09/2020
3Hypoxia (Hypoxemia)
08/2021 - 01/2011
3Acute Kidney Injury (Acute Renal Failure)
07/2021 - 01/2012
3Streptococcal Infections (Streptococcal Infection)
01/2019 - 01/2013
3Communicable Diseases (Infectious Diseases)
09/2017 - 01/2010
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2011 - 05/2009
2Dyslipidemias (Dyslipidemia)
02/2024 - 01/2021
2Hyperglycemia
01/2023 - 11/2022
2Body Weight (Weight, Body)
08/2022 - 11/2002
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2022 - 07/2012
2Cognitive Dysfunction
03/2022 - 11/2020
2Hypertension (High Blood Pressure)
01/2022 - 01/2021
2Obesity
01/2022 - 01/2021
2Obstructive Sleep Apnea
08/2021 - 01/2020
2Apnea
08/2021 - 01/2020
2Deglutition Disorders (Dysphagia)
01/2021 - 04/2014
2Dengue (Dengue Fever)
12/2020 - 06/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2020 - 09/2019
2Reinfection
01/2019 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
03/2016 - 11/2014
2Ataxia Telangiectasia (Louis Bar Syndrome)
02/2016 - 05/2012
2Acute Promyelocytic Leukemia
01/2015 - 03/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014 - 09/2012
2Starvation
01/2013 - 11/2012

Drug/Important Bio-Agent (IBA)

12CytokinesIBA
11/2021 - 01/2012
9Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2011
9InterferonsIBA
04/2022 - 10/2012
8Glycogen Synthase (Synthase I)IBA
04/2022 - 05/2009
6Glycogen Synthase Kinase 3IBA
04/2022 - 10/2011
6Antiviral Agents (Antivirals)IBA
01/2021 - 06/2013
6Glycogen Synthase KinasesIBA
01/2018 - 09/2009
5Propofol (Diprivan)FDA LinkGeneric
02/2024 - 03/2011
5Cisplatin (Platino)FDA LinkGeneric
07/2021 - 08/2011
5CeramidesIBA
10/2011 - 04/2008
4IntegrinsIBA
04/2024 - 10/2019
4Therapeutic UsesIBA
04/2024 - 07/2011
4Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2012
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021 - 10/2014
4CaspasesIBA
12/2020 - 11/2012
4Caspase 3 (Caspase-3)IBA
09/2019 - 11/2012
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 09/2010
4SphingolipidsIBA
10/2011 - 01/2011
4Type A Botulinum Toxins (Botox)FDA Link
07/2011 - 04/2004
3OvalbuminIBA
04/2024 - 08/2021
3PaxillinIBA
04/2024 - 01/2021
3Anesthetics (Anesthetic Agents)IBA
02/2024 - 03/2011
3Hypnotics and Sedatives (Sedatives)IBA
08/2021 - 01/2021
3Small Interfering RNA (siRNA)IBA
01/2021 - 10/2012
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 01/2013
3LipidsIBA
11/2015 - 04/2008
3ceramide glucosyltransferaseIBA
08/2015 - 10/2011
3Interleukin-10 (Interleukin 10)IBA
11/2014 - 09/2009
3Macrophage Migration-Inhibitory FactorsIBA
10/2014 - 01/2012
2SialyltransferasesIBA
04/2024 - 01/2021
2salicylhydroxamic acid (SHAM)IBA
04/2024 - 01/2020
2Anti-Bacterial Agents (Antibiotics)IBA
05/2023 - 10/2019
2Antineoplastic Agents (Antineoplastics)IBA
04/2023 - 11/2014
2Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA
01/2023 - 11/2022
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2022 - 01/2021
2Viral ProteinsIBA
11/2022 - 01/2017
2Metalloproteases (Metalloproteinases)IBA
08/2021 - 01/2021
2DisintegrinsIBA
08/2021 - 01/2021
2ChemokinesIBA
07/2021 - 01/2019
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2017
2Particulate MatterIBA
11/2020 - 09/2019
2Butylated Hydroxytoluene (BHT)IBA
12/2019 - 01/2019
2NADPH Oxidases (NAD(P)H oxidase)IBA
01/2019 - 01/2018
2AutoantibodiesIBA
01/2019 - 01/2019
2Transcription Factors (Transcription Factor)IBA
09/2017 - 01/2015
2Galectin 3 (LGALS3)IBA
03/2016 - 08/2011
2TensinsIBA
03/2016 - 10/2015
21,4- bis(di(5- hydroxy- 1H- indol- 3- yl)methyl)benzeneIBA
11/2015 - 01/2014
2AlkaloidsIBA
08/2015 - 05/2012
2Vinorelbine (Navelbine)FDA LinkGeneric
08/2015 - 07/2014
2Interleukin-6 (Interleukin 6)IBA
01/2015 - 01/2010
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2015 - 08/2011
2dicarboxydine (DCD)IBA
09/2014 - 07/2012
2p38 Mitogen-Activated Protein KinasesIBA
11/2012 - 10/2011
2Annexin A2 (Annexin II)IBA
09/2012 - 10/2009

Therapy/Procedure

18Therapeutics
09/2023 - 03/2010
10Activities of Daily Living (ADL)
01/2023 - 04/2010
5Aftercare (After-Treatment)
01/2023 - 12/2012
5Mirror Movement Therapy
01/2023 - 10/2017
3Stroke Rehabilitation
03/2024 - 04/2010
3Neurological Rehabilitation
01/2020 - 05/2017
3Drug Therapy (Chemotherapy)
08/2011 - 04/2008